%sitename% - Page 8 of 10 - Creating the Future of Drug Discovery Together - Page 8 of 10 - Creating the Future of Drug Discovery Together

A photo of various tablets and capsules scattered around a small container that has tipped over.

Issue No. 6: Expectations for Drug Discovery and Health Research Using Simple Model Organisms – From the Perspective of ICT Utilization

2024.07.05
This series is based on the recognition that “drug development is entering a major t… 黒澤伸行

A close-up photo of several blister packs filled with red tablets.

Issue No. 5: Urgent Need for Building Co-Creation Platforms and Developing ICT Talent

2024.07.03
This series is based on the recognition that “drug development is entering a major turning point,” with its main theme… 黒澤伸行

A photo of several blister packs containing tablets arranged on a table.

Issue No. 4: How to Navigate the Second Internet Revolution and the New Wave of Artificial Intelligence?

2024.07.03
In this series, we have been reviewing the drastic changes in the research and development environment for drug creation since around 2010. In the … 黒澤伸行

A photo of a small dish filled with white tablets placed on large green leaves.

Issue No. 3: Can the ‘Pipeline’ of Drug Development Be Reconsidered?

2024.06.29
This series begins with the recognition that drug development is entering a significant turning point. The main theme is to anticipate the next era from th… 黒澤伸行

A photo of various tablets and capsules in different colors and shapes placed on a white background.

Issue No. 2: From Drug Discovery and Development to Precision Medicine

2024.06.21
Recently, three acquisition reports in the pharmaceutical industry have drawn significant attention: Takeda Pharmaceutical’s acqui… 黒澤伸行

A photo of multiple white round tablets piled together on a white background.

Issue No. 1: Drug Development at a Crisis or Turning Point

2024.06.14
The author has no prior experience working in a pharmaceutical company nor direct involvement in drug resea… 黒澤伸行

An open office with large windows at sunset, with a lounge area in the foreground.

Session 6: What Is True Marketing?

2025.01.09
【Hisashi Iwase】 For someone like me in my 40s, caught up in the whirlwind of dramatic corporate mergers and acquisitions, these experiences became invaluable to my social and professional life thereaft… 黒澤伸行

An open office space with white desks and chairs, illuminated by natural light from large windows.

Session 5: The Beginning of a New Survival Era

2025.01.15
【Hisashi Iwase】 In June 2007, PerSeptive Biosystems Japan Corporation received the “No. 1 Sales Award.” A total of 14 members, including all sales representatives and marketing team members, were invited to the U.S. head.… 黒澤伸行

A bright office lounge with sofas and indoor plants, featuring large windows overlooking a city skyline.

Session 4: Contributing to the Launch of U.S. Venture Companies

2025.01.15
【Hisashi Iwase】 PerSeptive Biosystems was likely named by combining “Perfusion” and “Perspective” to create the term “PerSeptive.” The founder, Dr. Noubar Afeyan, was only 30 years old at the time. After graduating fro… 黒澤伸行

Session 3: Corporate Acquisitions and Spin-Outs to Ventures

2025.01.15
【Hisashi Iwase】 On a summer evening in July 1995, my colleague, Sales Manager Mr. Y, and I were in a Boston sports bar, reflecting on the day with Samuel Adams beers in hand.“So, what… 黒澤伸行

Issue No. 6: Expectations for Drug Discovery and Health Research Using Simple Model Organisms – From the Perspective of ICT Utilization

Issue No. 5: Urgent Need for Building Co-Creation Platforms and Developing ICT Talent

Issue No. 4: How to Navigate the Second Internet Revolution and the New Wave of Artificial Intelligence?

Issue No. 3: Can the ‘Pipeline’ of Drug Development Be Reconsidered?

Issue No. 2: From Drug Discovery and Development to Precision Medicine

Issue No. 1: Drug Development at a Crisis or Turning Point

Session 6: What Is True Marketing?

Session 5: The Beginning of a New Survival Era

Session 4: Contributing to the Launch of U.S. Venture Companies

Session 3: Corporate Acquisitions and Spin-Outs to Ventures

Popular articles/人気記事

Recent Posts/最近の投稿

Event Schedule

Issue No. 6: Expectations for Drug Discovery and Health Research Using Simple Model Organisms – From the Perspective of ICT Utilization

Issue No. 5: Urgent Need for Building Co-Creation Platforms and Developing ICT Talent

Issue No. 4: How to Navigate the Second Internet Revolution and the New Wave of Artificial Intelligence?

Issue No. 3: Can the ‘Pipeline’ of Drug Development Be Reconsidered?

Issue No. 2: From Drug Discovery and Development to Precision Medicine

Issue No. 1: Drug Development at a Crisis or Turning Point

Session 6: What Is True Marketing?

Session 5: The Beginning of a New Survival Era

Session 4: Contributing to the Launch of U.S. Venture Companies

Session 3: Corporate Acquisitions and Spin-Outs to Ventures

Popular articles/人気記事

Recent Posts/最近の投稿

Event Schedule

Tag Cloud